ElsMed Israel, Novatec and IBA sign contract to establish radiopharmaceutical production centre in Georgia
The project will be the first of its kind in Georgia and includes the construction of an ultra-modern radiopharmaceutical facility equipped with the latest technologies such as the IBA’s Cyclone® KIUBE and Synthera®+ platform. The center will produce various types of radiopharmaceutical products and is expected to start operations in 2024.
The design, construction, operation, and production processes of the facility will be developed by ElsMed and in line with the International Atomic Energy Agency (IAEA) standards and recommendations from IBA, as well as meeting set requirements defined by the legislation of Georgia.
The facility will be able to fully cover the current and future demand of the Georgian market, both in terms of production and delivery of fluorodeoxyglucose (18F-FDG) as well as other artificial radioactive isotopes.”
ElsMed being additionally involved in the facility design and training of necessary personnel, in cooperation with leading nuclear medicine centres in Israel, and will provide continuous support until project completion.”
About Novatec International
Novatec International LLC is a Georgian company founded to create and develop a radiopharmaceutical production in order to fulfil Georgia demand for various PET CT isotopes. The main stakeholders of the Novatec International are well known in Eastern Europe countries healthcare sector with experience in establishing a state-of-the-art medical centre.
© ElsMed Healthcare Solutions